Understanding Pulmonary Arterial Hypertension and Its Treatment Options
Nurses play a key role in the management of patients with PAH and often assume a number of responsibilities that include but are not limited to care coordination, patient assessment, medication administration, patient education, and patient advocacy. This activity will strengthen learners’ foundational knowledge and competency regarding PAH, and enable the application of new information and skills to authentic clinical situations.
- Describe the epidemiology, pathogenesis, and classification of pulmonary arterial hypertension (PAH)
- Comprehensively assess the risk factors, signs, and symptoms of new and worsening PAH
- Identify currently available pharmacotherapies for PAH and appropriately administer them to patients
- Recognize the adverse effects associated with drugs used to treat PAH and appropriately counsel patients
Nurses, Clinical Nurse Specialists, Advanced Practice Nurses
Supporter Acknowledgment Statement
This activity supported by educational grant funding from Actelion Pharmaceuticals US, Inc.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Traci Stewart, RN, MSN, CHFN
The University of Iowa
Heart and Vascular Center
University of Iowa
Columbus Junction, IA
Traci Stewart has over twenty years of clinical expertise in management of pulmonary hypertension (PH) and heart failure (HF) patients as a nurse clinician specialist in the Advanced Heart and Lung Program at the University of Iowa. She has her Masters in Nursing and is a certified HF nurse. She facilitates a regional PH support group and organizes and presents education on PH/HF disease management to patients and healthcare providers in the community. She is a past chair of Pulmonary Hypertension Professional Network and serves on the Pulmonary Hypertension Association board of trustees.
Ty J. Gluckman, MD, FACC, FAHA
Medical Director of Clinical Transformation
Providence Heart and Vascular Institute
Ty J. Gluckman, MD, FACC, FAHA is Medical Director of Clinical Transformation at the Providence Heart and Vascular Institute in Portland, Oregon and an adjunct faculty member of the Ciccarone Center for the Prevention of Heart Disease at The Johns Hopkins Hospital in Baltimore, Maryland. Dr. Gluckman graduated summa cum laude with highest honors from Brandeis University and received his medical degree from Northwestern University Medical School in Chicago, Illinois. He completed his internal medicine training at McGaw Medical Center of Northwestern University, where he remained for additional years as chief resident and an Instructor of Medicine. He completed his cardiology fellowship training at The Johns Hopkins Hospital and served as chief fellow during his final year there.
Dr. Gluckman’s principal clinical interests include identifying, coordinating, and implementing cardiovascular care improvement strategies. He has authored or co-authored over 50 peer-reviewed scientific articles, reviews, and book chapters. His work has been published in several high-impact journals including Archives of Internal Medicine, JAMA, JAMA Cardiology, the Journal of the American College of Cardiology, and the Journal of the American Heart Association. For the last 3 years, Dr. Gluckman has led the Interprofessional Practice track at the National Cardiovascular Data Registry (NCDR) annual meeting. He serves as Associate Editor for Practice Guidelines and Clinical Documents for ACC.org, the primary web site for the American College of Cardiology (ACC). He is an active councilor, Director of Quality, and Governor-Elect for the Oregon Chapter of the ACC and the National Clinical Quality Expert for the ACC Patient Navigator Program. Dr. Gluckman was lead developer for the ACC/AHA Atherosclerotic Cardiovascular Disease (ASCVD) Risk Estimator app, selected as the best medical app in 2014 and more recently, helped to design the AnticoagEvaluator and BridgeAnticoag apps. Dr. Gluckman recently completed the Health Management Academy GE Fellows Program for Physician Executives and was selected by Cardiology Today as a “Next Gen Innovator”.
Ms. Stewart has served as a consultant for Actelion, Gilead, and Bayer.
Dr. Gluckman does not have any relevant financial relationships within the past 12 months with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Role: External Reviewer
Disclosure for Non-faculty Contributors/Planners
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
This continuing nursing education activity was approved by Oregon Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
Approval valid through 1/15/2020
OCEAN ID #2017-24
Credit Designation Statement
This activity has received OCEAN approval for 1.0 contact hours.
Requirements for Receiving your Certificate for Contact Hours
Within 30 days of the activity, you must:
- Complete the activity
- Complete the immediate post-test and respond correctly to 75% of the questions with a maximum of 10 attempts
- Complete the evaluation
How to Access Your Certificate
After completing the activity evaluation, you will be directed to the Course Dashboard.
- Click on "Event Materials."
- In the section "Event Certificates," select "ANCC. "
- Click "Claim & View Certificate" to download the PDF file of your certificate.
This activity will be available for awarding contact hours from January 15, 2018 to January 15, 2020.
If you have any questions, please e-mail email@example.com.